Complement therapeutics meets nanomedicine: overcoming human complement activation and leukocyte uptake of nanomedicines with soluble domains of CD55-Reference-Cited by-同舟云学术

Complement therapeutics meets nanomedicine: overcoming human complement activation and leukocyte uptake of nanomedicines with soluble domains of CD55

Published:2019-05 Issue: Volume:302 Page:181-189
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Gifford Geoffrey,Vu Vivian P.,Banda Nirmal K.,Holers V. Michael,Wang Guankui,Groman Ernest V.,Backos Donald^ORCID,Scheinman Robert,Moghimi S. Moein,Simberg Dmitri^ORCID

Funder

NIH

International Science and Technology Cooperation of Guangdong Province

Guangzhou City

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference57 articles.

1. Material properties in complement activation;Moghimi;Adv. Drug Deliv. Rev.,2011

2. C1q-mediated complement activation and C3 opsonization trigger recognition of stealth poly(2-methyl-2-oxazoline)-coated silica nanoparticles by human phagocytes;Tavano;ACS Nano,2018

3. Modulatory role of surface coating of superparamagnetic iron oxide nanoworms in complement opsonization and leukocyte uptake;Inturi;ACS Nano,2015

4. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution;Dobrovolskaia;Mol. Pharm.,2008

5. Complement: a key system for immune surveillance and homeostasis;Ricklin;Nat. Immunol.,2010

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms and Barriers in Nanomedicine: Progress in the Field and Future Directions;ACS Nano;2024-05-20

2. Validation of dot blot immunoassay for measurement of complement opsonization of nanoparticles;Journal of Immunological Methods;2024-05

3. Exploring and Analyzing the Systemic Delivery Barriers for Nanoparticles;Advanced Functional Materials;2023-11-20

4. Inhibition of acute complement responses towards bolus-injected nanoparticles using targeted short-circulating regulatory proteins;Nature Nanotechnology;2023-10-05

5. Perspectives on complement and phagocytic cell responses to nanoparticles: From fundamentals to adverse reactions;Journal of Controlled Release;2023-04